Vyome Holdings (HIND) said Monday it has bought substantially all the assets of AI-startup Oculo, which was launched at the Massachusetts Institute of Technology.

The company said it has launched a new business unit focused on using AI to tackle inflammation, which will use Oculo's assets to develop an AI psychiatrist trained on data from both the US and India.

Vyome's shares were up more than 8% in recent Monday premarket activity.